EIP
LLY icon

Ellis Investment Partners’s Eli Lilly LLY Stock Holding History

Ellis Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
941
-20
-2% -$20.4K 0.17% 109
2026
Q1 		$885K Buy
961
+55
+6% +$55.8K 0.15% 117
2025
Q4 		$974K Sell
906
-262
-22% -$251K 0.17% 107
2025
Q3 		$891K Buy
1,168
+12
+1% +$8.93K 0.16% 106
2025
Q2 		$901K Buy
1,156
+2
+0.2% +$1.55K 0.18% 102
2025
Q1 		$953K Sell
1,154
-55
-5% -$45.8K 0.2% 98
2024
Q4 		$933K Buy
1,209
+82
+7% +$67.9K 0.18% 101
2024
Q3 		$998K Sell
1,127
-116
-9% -$104K 0.19% 98
2024
Q2 		$1.12M Buy
1,243
+102
+9% +$81.6K 0.24% 83
2024
Q1 		$888K Sell
1,141
-69
-6% -$49.1K 0.19% 96
2023
Q4 		$706K Sell
1,210
-160
-12% -$93.4K 0.16% 110
2023
Q3 		$736K Hold
1,370
– – 0.19% 97
2023
Q2 		$643K Buy
1,370
+359
+36% +$151K 0.16% 113
2023
Q1 		$347K Buy
1,011
+154
+18% +$51.9K 0.09% 157
2022
Q4 		$314K Sell
857
-15
-2% -$5.32K 0.09% 162
2022
Q3 		$282K Buy
872
+3
+0.3% +$951 0.08% 159
2022
Q2 		$281K Buy
869
+3
+0.3% +$901 0.08% 164
2022
Q1 		$248K Buy
866
+3
+0.3% +$772 0.06% 188
2021
Q4 		$238K Buy
863
+111
+15% +$28.1K 0.05% 197
2021
Q3 		$173K Buy
752
+73
+11% +$18K 0.04% 231
2021
Q2 		$156K Buy
679
+101
+17% +$20.3K 0.04% 242
2021
Q1 		$108K Sell
578
-7
-1% -$1.37K 0.03% 278
2020
Q4 		$99K Sell
585
-164
-22% -$24.5K 0.03% 284
2020
Q3 		$111K Buy
749
+2
+0.3% +$310 0.04% 250
2020
Q2 		$122K Buy
747
+3
+0.4% +$460 0.05% 227
2020
Q1 		$101K Buy
744
+135
+22% +$18.5K 0.05% 192
2019
Q4 		$80K Buy
609
+2
+0.3% +$232 0.03% 270
2019
Q3 		$67K Buy
607
+526
+649% +$58.6K 0.02% 295
2019
Q2 		$9K Buy
+81
New +$9.54K ﹤0.01% 534

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ellis Investment Partners's LLY Position: Q2 2026 in Review

Ellis Investment Partners reduced its Eli Lilly (LLY) stake by 2.1% in Q2 2026, selling an estimated $20.4K and leaving 941 shares worth $1.13M. The position accounts for 0.17% of the portfolio, ranked #109.

Ellis Investment Partners first reported a position in LLY in Q2 2019 and has held it in 29 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ellis Investment Partners held 941 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Ellis Investment Partners sold 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.17% of Ellis Investment Partners's portfolio in Q2 2026, its #109 holding.
  • Ellis Investment Partners first reported a position in Eli Lilly in Q2 2019 and has held it in 29 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.